Navigating the Landscape of Psoriasis Therapy: Novel Targeted Pathways and Emerging Trends

The authors focus on intracellular and molecular mechanisms such as AhR, A3AR, RIP1, CGRP, and S1P that serve as novel pharmacological targets for psoriasis, and on new molecules now approved or under clinical investigation to interfere with these target mechanisms.